Skip to Content
Morningstar

Evotec SE ADR EVO

Morningstar Rating
Unlock
Stock XNAS Rating as of
$7.65 +0.29 (3.94%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Positive Outlook on Evotec's Growth Thanks to CDMO Outsourcing Trends and Investment in the Pipeline

Rachel Elfman, Ava Gams

Evotec is a drug discovery partnership firm that has a contract development and manufacturing organization, or CDMO, business, in addition to an innovative drug development program focused on collaboration with clients. The firm offers services across a variety of therapeutic areas and serves a diverse client base of large and midsize pharmaceutical and biotechnology companies. Following a recent period of investment that has weighed on returns, Evotec appears well positioned to mature and stabilize its business as its strategic growth initiatives materialize.

Read Full Report

Price vs Fair Value

View History
EVO is trading at a 3% discount.
Price
$7.36
Fair Value
$4.10
Uncertainty
High
1-Star Price
$32.51
5-Star Price
$7.37
Economic Moat
Htv
Capital Allocation
Chblgxfd

Bulls Say, Bears Say

Bulls

Evotec’s focus on building out its biologics manufacturing capacity makes it well positioned to capture heightened demand for biologics by biopharma companies.

Bears

Competitive market dynamics remain fierce, weighing on Evotec’s organic growth in the Execute segment and putting pricing pressure on the firm’s more commoditized services.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EVO is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$7.36
Day Range
$7.57–7.77
52-Week Range
$6.83–13.49
Bid/Ask
$7.62 / $7.80
Market Cap
$2.71 Bil
Volume/Avg
33,841 / 50,199

Key Statistics

Price/Earnings (Normalized)
29.24
Price/Sales
2.92
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The EVT Execute segment, about 75% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment, about 25% of sales, develops proprietary drug discovery programs and assets, which can lead to partnerships with clients. As of 2022, the company has almost 5,000 employees and 17 production sites mainly in Europe and the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Growth
Total Number of Employees
5,086
Website
https://www.evotec.com

Competitors

Valuation

View More
Metric
EVO
CTLT
LONN
Price/Earnings (Normalized)
 29.2497.9731.81
Price/Book Value
 2.122.733.89
Price/Sales
 2.922.475.60
Price/Cash Flow
 75.4954.1628.24
Price/Earnings
EVO
CTLT
LONN

Financial Strength

Metric
EVO
CTLT
LONN
Quick Ratio
 1.931.541.12
Current Ratio
 2.162.481.77
Interest Coverage
 −6.83−5.239.00
Quick Ratio
EVO
CTLT
LONN

Profitability

Metric
EVO
CTLT
LONN
Return on Assets (Normalized)
 −4.21%−2.51%5.28%
Return on Equity (Normalized)
 −8.08%−6.08%9.02%
Return on Invested Capital (Normalized)
 −5.57%−0.60%7.29%
Return on Assets
EVO
CTLT
LONN
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRBrshkfydlRjvcnns$71.2 Bil
ZTS
Zoetis Inc Class AGblkznjgxhZjgpk$68.3 Bil
HLN
Haleon PLC ADRLbhhdzrqJnst$37.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRPrfkktdMnrr$14.5 Bil
VTRS
Viatris IncKlmsctlbpKyr$13.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRVnmjdwzfQkp$11.9 Bil
CTLT
Catalent IncXyhwmbhvRzdxbcb$10.1 Bil
PRGO
Perrigo Co PLCBwcwmjqKjfk$4.1 Bil
CURLF
Curaleaf Holdings IncDvpfwhfqVhty$3.6 Bil
PBH
Prestige Consumer Healthcare IncSqvmthrzQnknx$3.5 Bil

Sponsor Center